Cargando…
Medication-related osteonecrosis of the jaw: a preliminary retrospective study of 130 patients with multiple myeloma
BACKGROUND: Multiple myeloma (MM) is characterized by a neoplastic proliferation of plasma cells primarily in the bone marrow. Bisphosphonates (BP) are used as supportive therapy in the management of MM. This study aimed to analyze the incidence, risk factors, and clinical outcomes of medication-rel...
Autores principales: | Choi, Woo-Sung, Lee, Jae-Il, Yoon, Hyun-Joong, Min, Chang-Ki, Lee, Sang-Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216009/ https://www.ncbi.nlm.nih.gov/pubmed/28101496 http://dx.doi.org/10.1186/s40902-016-0099-4 |
Ejemplares similares
-
Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients
por: Walter, Christian, et al.
Publicado: (2010) -
Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma
por: Krstevska, Svetlana, et al.
Publicado: (2015) -
Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
por: Melea, Pelagia I., et al.
Publicado: (2014) -
Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report
por: Lee, Jeong Keun, et al.
Publicado: (2013) -
Concomitant Factors Leading to an Atypical Osteonecrosis of the Jaw in a Patient with Multiple Myeloma
por: Miranda-Rius, Jaume, et al.
Publicado: (2014)